Scantox Group has released the 2023 Annual Report today. It highlights the many activities our company has done over the year to shape the future of a business that in so many ways contribute to improve lives worldwide through the development of new drugs and treatments. Martin Amtoft-Christensen, CFO Scantox Group : ”We are pleased … Read more